TrialJAMA network open2022

Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis.

Runsheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.